What is the current Price Target for the RAPT Therapeutics Inc stock?

The average RAPT Therapeutics Inc target price is $32.64. This is 305.47% higher than the current stock price. The highest price target is 526.09%, the lowest is 0.37%. 6 Analysts have issued a price target RAPT Therapeutics Inc 2026 .

How high will the RAPT Therapeutics Inc stock rise?

No reliable answer can be given as to how high the RAPT Therapeutics Inc stock will rise. The performance of stocks, including the RAPT Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the RAPT Therapeutics Inc stock today?

The performance of RAPT Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the RAPT Therapeutics Inc stock fall?

The decline in RAPT Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

RAPT Therapeutics Inc Forecast, price target & analysts

$8.05

0.50%

Nasdaq, Jul 03, 07:00 pm CET

ISIN

US75382E1091

Symbol

RAPT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

RAPT Therapeutics Inc Target price 2025 - Analyst rating & recommendation

RAPT Therapeutics Inc Classifications & Recommendation:

Buy

64%

Hold

27%

Sell

RAPT Therapeutics Inc Price Target

Target Price	$32.64
Price	$8.05
Potential	305.47% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target RAPT Therapeutics Inc 2026 . The average RAPT Therapeutics Inc target price is $32.64. This is 305.47% register free of charge higher than the current stock price. The highest price target is $50.40 526.09% register free of charge , the lowest is $8.08 0.37% register free of charge .
	A rating was issued by 11 analysts: 7 Analysts recommend RAPT Therapeutics Inc to buy, 3 to hold and 1 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the RAPT Therapeutics Inc stock has an average upside potential 2026 of 305.47% register free of charge . Most analysts recommend the RAPT Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-25.51	-2.87
	4.51%	88.75%
P/E		negative

7 Analysts have issued a RAPT Therapeutics Inc forecast for earnings per share. The average RAPT Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-25.51	4.51%
2025	$-2.87 88.75% Unlock
2026	$-3.69 28.57% Unlock
2027	$-2.59 29.81% Unlock
2028	$-4.20 62.16% Unlock
2029	$-4.69 11.67% Unlock
2030	$-2.86 39.02% Unlock

Current	-1.87	88.43%
2025	-2.80 49.56% Unlock
2026	-2.18 22.14% Unlock
2027	-3.11 42.66% Unlock
2028	-1.92 38.26% Unlock
2029	-1.72 10.42% Unlock
2030	-2.82 63.95% Unlock

RAPT Therapeutics Inc...

Current RAPT Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
UBS	Locked ➜ Locked	Locked	May 22 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 10 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 26 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 25 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 12 2024
Wells Fargo	Locked ➜ Locked	Locked	Nov 12 2024
JP Morgan	Locked ➜ Locked	Locked	Nov 11 2024

Analyst Rating	Date
Locked UBS: Locked ➜ Locked	May 22 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 10 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 26 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 25 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 12 2024
Locked Wells Fargo: Locked ➜ Locked	Nov 12 2024
Locked JP Morgan: Locked ➜ Locked	Nov 11 2024

Discover more stocks with a high price target

Alibaba Group Holding Ltd 55.07%

Tencent Holdings Ltd. 30.37%

Adyen 29.68%

Adidas 29.43%

BioNTech SE - ADR 27.50%

Deutsche Telekom 25.72%

Siemens 15.22%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now